期刊文献+

乳糖诱导重组尿酸酶基因在大肠杆菌中的表达 被引量:11

Expression of Recombinant Uricase in E. coli JM109(DE3) Induced by Lactose
原文传递
导出
摘要 对用乳糖替代异丙基-β-D-硫代半乳糖苷(IPTG)诱导重组产朊假丝酵母尿酸酶基因在E.coliJM109(DE3)中表达进行了研究,拟建立一种高效低成本的生产重组尿酸酶的工艺路线。通过摇瓶试验对诱导所采用的乳糖浓度,诱导时机和诱导持续时间进行了优化,并考察在乳糖诱导下的目的产物表达动力学,随后在5L发酵罐上进行扩大化培养以验证摇瓶优化的结果,进一步将乳糖作为诱导剂应用于高密度发酵过程。实验结果表明乳糖诱导的最佳浓度为5g/L,最佳诱导时机是对数生长期中后期,诱导持续时间为9~10h;按照优化的条件在摇瓶和5L发酵罐上进行分批培养,重组尿酸酶最大表达量可达菌体总蛋白的26%左右,可溶性蛋白的36%左右,略高于IPTG的诱导效果;高密度发酵过程菌体终密度达到OD600值40以上,尿酸酶表达量占菌体总蛋白25%左右。 Using lactose as a succedaneous inducer of IPTG to induce the expression of Candida utilis uricase gene cloned in E. coli JM109(DE3) was deeply investigated for establishing a high-performance but low-cost method of recombinant uricase production. The adopted lactose concentration for induction, the time point of induction, the duration of induction and the dynamics of uricase expression were optimized and studied in detail by shake flask experiment. The results of optimization were verified by enlarged fermentation in 5 L fermentor and then lactose was used as the inducer in the high density fermentation. As showed by the experiments, the best inducing concentration of lactose was 5 g/L, the midanaphase of logarithmic phase was the best time for induction and the duration of induction were 9 -10h; according to the optimum conditions, compared with IP-FG, both in the shake flask and 5 L fermentor with batch culture, the better inducing effect could be obtained: the expression level of uricase was about 26% of the total bacterial protein and about 36% of the soluble protein, the final cell density (OD600) was over 40 in the 5 L fermentor and uricase expression level was about 25% with high density fermentation.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2009年第7期74-79,共6页 China Biotechnology
基金 国家科技支撑计划资助项目(2006BAF07B01)
关键词 尿酸酶 乳糖 诱导表达 优化 高密度发酵 Uricase Lactose Induced expression Optimization High density fermentation
  • 相关文献

参考文献12

  • 1Oda M,Satta Y,Takenaka O,et al.Loss of urate oxidase activity in hominoids and its evolutionary implications.Mol Biol Evol,2002,19(5):640-653.
  • 2Ronco C,Bellomo R,Inguaggiato P,et al.Rasburicase therapy in acute hypemricemic renal dysfunction.Contrib Nephrol,2004,144:158-165.
  • 3Duncan P H,Gochman N,Cooper T,et al.A candidate reference method for uric acid in serum.I.Optimization and evaluation.Clin Chem,1982,28(2):284.
  • 4朱献军,刘建国,黎高翔.尿酸氧化酶基因的克隆、表达及其产物的应用[J].生物工程学报,2001,17(1):68-72. 被引量:18
  • 5吴伟立,李彦英,苗林,徐金森,方宏清,陈惠鹏.尿酸氧化酶的表达纯化及活性形式鉴定[J].军事医学科学院院刊,2005,29(2):124-126. 被引量:2
  • 6刘广桢,陈建华,王旻.尿酸酶产生菌的筛选、基因克隆及表达[J].中国药科大学学报,2005,36(5):464-467. 被引量:10
  • 7Li J M,Chen Z,Hou L H,et al.Hish-level expression,purification,and characterization of non tagged aspergillus Xavus urste oxidase in Escherichia coil.Protein Expression and Purification,2006,49:55-59.
  • 8Ausubel F M,Blent R,Kingston R E,et al.Shm Protocols in Molecular Biology.3rd ed,New York:John Wiley & Sons Inc,1995.333-351.
  • 9汪家政 范明.蛋白质技术手册[M].北京:科学出版社,2002(第一版).51-54.
  • 10张毅,屈贤铭,杨胜利.乳糖作为诱导剂对重组目的蛋白表达的影响[J].生物工程学报,2000,16(4):464-468. 被引量:62

二级参考文献45

  • 1李春丽,何国庆,阮晖,陈正华.des-pGLU1-Bra基因的人工合成及其在大肠杆菌中的重组表达[J].农业生物技术学报,2005,13(1):38-41. 被引量:9
  • 2刘建国,黎高翔.假丝酵母尿酸酶形成条件[J].微生物学报,1989,29(1):45-50. 被引量:3
  • 3张毅,生物工程学报,2000年,16期,24页
  • 4Lin L L,Lett Appl Microbiol,1997年,24期,365页
  • 5Liu J G,Appl Biochem Biotechnol,1994年,47卷,1期,57页
  • 6Wu X,Proc Nat Acad Sci USA,1989年,86卷,23期,9412页
  • 7Ronco C,Bellomo R,Inguaggiato P,et al. Rasburicase therapy in acute hyperuricemic renal dysfunction[J]. Contrib Nephrol,2004,144:158 -165.
  • 8Bomalaski JS,Clark MA. Serum uric acid-lowering therapies:where are we heading in management of hyperuricemia and the potential role of uricase[J]. Curr Rheumatol Rep,2004,6(3):240 -247.
  • 9Lee AC,Li CH,So KT,et al. Treatment of impending tumor lysis with single-dose rasburicase[J]. Ann Pharmacother,2003,37(11):1 614 -1 617.
  • 10Hummel M,Buchheidt D,Reiter S,et al. Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome[J]. Leukemia,2003,17(12):2 542 -2 544.

共引文献162

同被引文献97

引证文献11

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部